Singapore's sovereign wealth fund GIC Private Limited has agreed to invest HK$659 million (US$85 million) into Hong Kong-listed Chinese biomedicine firm Bloomage BioTechnology Corporation Limited, according to a company announcement. GIC will become a key shareholder of the company to support its expansion in China's aesthetic medical market through organic growth and acquisitions. "GIC believes […]

Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.